Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort

Qi Ding, Yu-Xuan Xu, Wei-Ling Sun, Jing-Jing Liu, Yu-Yu Deng, Qiao-Fang Wu, Chun-Yu Cao, Lan-Bo Zhou, Yan Lu, Wei-Xin Fan, Qi Ding, Yu-Xuan Xu, Wei-Ling Sun, Jing-Jing Liu, Yu-Yu Deng, Qiao-Fang Wu, Chun-Yu Cao, Lan-Bo Zhou, Yan Lu, Wei-Xin Fan

Abstract

Objective: To describe the clinical features of early-onset androgenetic alopecia (AGA) in a large cohort of Chinese patients.

Methods: This descriptive study recruited consecutive patients seeking medical treatment for AGA between 1 January 2013 and 30 November 2018. Patients were included in the study if they reported being ≤35 years old at AGA onset and if their pattern of hair loss was documented with photographs. The age of onset, sex, body mass index (BMI), BAsic and SPecific classification of hair loss and family history of alopecia were collected in an electronic database.

Results: A total of 3897 patients with early-onset AGA were recruited to the study. The majority of patients (70.6%; 2751 of 3897) were 21–30 years old and male (72.7%; 2834 of 3897). No association was found between high BMI (≥25 kg/m2) and early-onset AGA. There were significantly more overweight male AGA patients than overweight female patients (86.8% [632 of 728] versus 13.2% [96 of 728], respectively). The overall prevalence of familial AGA was 72.8% (2837 of 3897) and the condition was inherited more often from the father (52.8%; 1498 of 2837) than from the mother (24.3%; 688 of 2837).

Conclusions: Early-onset AGA primarily affects male patients between 21–30 years of age. Males with early-onset AGA are likely to have inherited AGA from their fathers.

Keywords: Androgenetic alopecia; age distribution; early onset; family history.

Figures

Figure 1.
Figure 1.
Anatomical regions of the scalp (a). The BAsic and SPecific classification systems (b). Four BAsic types (L, M, C and U) and two SPecific types (frontal [F] and vertex [V]). L, no recession is observed in the frontotemporal region; M, recession in the frontotemporal hairline is more obvious than the mid-anterior hairline; C, recession in the mid-anterior hairline is more obvious than the frontotemporal hairline; U, the anterior hairline recedes to the vertex forming a horseshoe shape.,
Figure 2.
Figure 2.
Dermoscopic photographs showing representative images of the different stages and severities of androgenetic alopecia used in this current study.
Figure 3.
Figure 3.
Age distribution of patients with early-onset androgenetic alopecia (a). Comparison of the sex of patients with early-onset androgenetic alopecia according to the age distribution (b).
Figure 4.
Figure 4.
Body mass index (BMI) of male and female patients (n = 3685) with early-onset androgenetic alopecia.
Figure 5.
Figure 5.
Distribution of patients according to their family history of androgenetic alopecia (a). Comparison between the sexes of a positive family history of androgenetic alopecia (b).

References

    1. Piraccini BM andAlessandrini A.. Androgenetic alopecia. G Ital Dermatol Venereol 2014; 149: 15–24.
    1. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247–254.
    1. Kaliyadan F Nambiar A andVijayaraghavan S.. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol 2013; 79: 613–625.
    1. Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review. Endocrine 2017; 57: 9–17.
    1. Tosti A Iorizzo M andPiraccini BM.. Androgenetic alopecia in children: report of 20 cases. Br J Dermatol 2005; 152: 556–559.
    1. Kim BJ, Kim JY, Eun HC, et al. Androgenetic alopecia in adolescents: a report of 43 cases. J Dermatol 2006; 33: 696–699.
    1. Blume-Peytavi U, Blumeyer A, Tosti A, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 2011; 164: 5–15.
    1. Matilainen V Koskela P andKeinänen-Kiukaanniemi S.. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000; 356: 1165–1166.
    1. Severi G, Sinclair R, Hopper JL, et al. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol 2003; 149: 1207–1213.
    1. Su LH andChen TH.. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. Br J Dermatol 2010; 163: 371–377.
    1. Arias-Santiago S, Gutierrez-Salmeron MT, Castellote-Caballero L, et al. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol 2010; 63: 420–429.
    1. Chumlea WC, Rhodes T, Girman CJ, et al. Family history and risk of hair loss. Dermatology 2004; 209: 33–39.
    1. Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71–82.
    1. Lee WS, Ro BI, Hong SP, et al. A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification. J Am Acad Dermatol 2007; 57: 37–46.
    1. Zhou C andZhang JZ.. Interpretation of BASP classification for diagnosis and treatment of androgenetic alopecia in China. J Dermatol and Venereol 2016; 38: 325–327.
    1. Hu R, Xu F, Han Y, et al. Trichoscopic findings of androgenetic alopecia and their association with disease severity. J Dermatol 2015; 42: 602–607.
    1. Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 1951; 53: 708–728.
    1. Xu F, Sheng YY, Mu ZL, et al. Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study. Br J Dermatol 2009; 160: 629–632.
    1. Yang CC, Hsieh FN, Lin LY, et al. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J Am Acad Dermatol 2014; 70: 297–302.
    1. Norwood OT. Male pattern baldness classification and Incidence. South Med J 1975; 68: 1359–1365.
    1. Norwood OT andLehr B.. Female androgenetic alopecia: a separate entity. Dermatol Surg 2000; 26: 679–682.
    1. Fortes C, Mastroeni S, Mannooranparampil TJ, et al. The combination of overweight and smoking increases the severity of androgenetic alopecia. Int J Dermatol 2017; 56: 862–867.
    1. Nargis T, Bejai V, Pinto M, et al. Early onset androgenetic alopecia in men and associated risk factors: a hospital based study. Int J Res Dermatol 2017; 3: 267–271.
    1. Nyholt DR, Gillespie NA, Heath AC, et al. Genetic basis of male pattern baldness. J Invest Dermatol 2003; 121: 1561–1564.
    1. Yeo IK, Jang WS, Min PK, et al. An epidemiological study of androgenic alopecia in 3114 Korean patients. Clin Exp Dermatol 2014; 39: 25–29.
    1. Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol 2010; 162: 843–847.
    1. Jung JG Kim MH andCinn YW.. Comparison of androgenetic alopecia prevalence in paternal and maternal male family members of male androgenetic alopecia patients. Korean J Dermatol 2006; 44: 173–178.
    1. Jang WS, Son IP, Yeo IK, et al. The annual changes of clinical manifestation of androgenetic alopecia clinic in Korean males and females: a outpatient-based study. Ann Dermatol 2013; 25: 181–188.
    1. Lee WS, Oh Y, Ji JH, et al. Analysis of familial factors using the basic and specific (BASP) classification in Korean patients with androgenetic alopecia. J Am Acad Dermatol 2011; 65: 40–47.
    1. Hillmer AM, Flaquer A, Hanneken S, et al. Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. Am J Hum Genet 2008; 82: 737–743.
    1. Hillmer AM, Hanneken S, Ritzmann S, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet 2005; 77: 140–148.
    1. Nicoli F, Balzani A, Lazzeri D, et al. Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix. Int Wound J 2015; 12: 338–343.
    1. Cervelli V, Lucarini L, Spallone D, et al. Use of platelet-rich plasma and hyaluronic acid in the loss of substance with bone exposure. Adv Skin Wound Care 2011; 24: 176–181.
    1. Scioli MG, Bielli A, Gentile P, et al. Combined treatment with platelet-rich plasma and insulin favours chondrogenic and osteogenic differentiation of human adipose-derived stem cells in three-dimensional collagen scaffolds. J Tissue Eng Regen Med 2017; 11: 2398–2410.
    1. Gentile P, Garcovich S, Bielli A, et al. The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Transl Med 2015; 4: 1317–1323.
    1. Gentile P, Scioli MG, Orlandi A, et al. Breast reconstruction with enhanced stromal vascular fraction fat grafting: what is the best method? Plast Reconstr Surg Glob Open 2015; 3: e406.
    1. Gentile P, Scioli MG, Bielli A, et al. Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss. Stem Cell Investig 2017; 4: 58.
    1. Gentile P andGarcovich S.. Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: wnt pathway, growth-factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cells 2019; 8: pii: E466.
    1. Gentile P. Autologous cellular method using micrografts of human adipose tissue derived follicle stem cells in androgenic alopecia. Int J mol Sci 2019; 20: pii: E3446.
    1. Bao L, Yu A, Luo Y, et al. Genomewide differential expression profiling of long non-coding RNAs in androgenetic alopecia in a Chinese male population. J Eur Acad Dermatol Venereol 2017; 31: 1360–1371.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться